Opsona Therapeutics announces the issuance of new patent from the European ... MarketWatch (press release) TLR-2 plays an important role in the induction and progression of a number of non-pathogen associated inflammatory conditions including ischemia reperfusion injury (delayed graft function in renal transplantation, myocardial infarct), certain cancer, ... |
